About
Basic Data Updated:
1 month agoVista Pharmaceuticals Ltd is a company that is involved in the manufacturing and marketing of pharmaceutical products. These products, which include tablets, capsules, and liquids, cover a wide range of therapeutic categories. Some notable examples of the company's offerings are sulfamethoxazole and trimethoprim, bismuth subsalicylate, aspirin, chloroquine phosphate, frusemide, indomethacin, piroxicam, and nefidipine. The company, which was incorporated in 1991, has its registered office situated in Telangana.
Industry
Company Details
- Location
Nalgonda, Telangana, India
- Website12224421
- Telephone12224421
- Email Address12224421
- Social Media12224421
| CIN/LLPIN/FCRN | L24239TG1991PLC012264 |
| Company No. | 012264 |
| Stock Symbol | BSE : 524711 |
| Company Classification | Public Limited Indian Non-Government Company |
| Incorporation Date | 25 Jan 1991 |
| Date of AGM | 30 Sep 2023 |
| Date of Balance Sheet | 31 Mar 2023 |
| Listing Status | Listed |
| ROC Code | Roc Hyderabad |
Financials of Vista Pharmaceuticals Ltd.
Vista Pharmaceuticals Ltd., for the financial year ended 2023, experienced significant growth in revenue, with a 130.09% increase. The company also saw a substantial fall in profitability, with a 599.25% decrease in profit. The company's net worth moved up by a moderate rise of 3.06%.
Corporate Structure
Unlock access to Vista Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
People in Vista Pharmaceuticals Ltd.
Unlock and access historical data on people associated with Vista Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Executive Team (2)
MM
Murali Meraga
Managing DirectorAppointment Date: 14-Oct-2022
Status: Current
SP
Suneel Pachipala CFOAppointment Date: 20-Apr-2015
Status: Current
Board Members(8)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Vijaya Bank Creation Date: 23 Feb 2017 | ₹17.00 Cr | Open |
Industrial Development Bank Of India Creation Date: 28 Jan 1993 | ₹9.00 M | Open |
State Bank Of India Creation Date: 25 Jun 2015 | ₹8.00 Cr | Satisfied |
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vista Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vista Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alert
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Related Corporates (Common Directorship)
1 year 11 months 
Recent activity within the organization
Annual General Meeting
Vista Pharmaceuticals Ltd. last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
30 Sep 2023Balance Sheet
Vista Pharmaceuticals Ltd. has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Hyderabad.
31 Mar 2023Director Appointment
Divakar Reddy Yerrabommanahalli was appointed as a Director was appointed as a Director on 30 Sep 2019 & has been associated with this company since 4 years 7 months .
30 Sep 2019Charges
A charge with Vijaya Bank of Rs. 17.00 cr registered on 23 Feb 2017 with Charge ID 100091777 was modified on 17 Apr 2018.
17 Apr 2018Director Appointment
Umesh Virupakah Banakar was appointed as a Director was appointed as a Director on 24 Feb 2018 & has been associated with this company since 6 years 3 months .
24 Feb 2018
Recent News, Updates & Announcement
Board of Vista Pharmaceuticals approves allotment of 189 lakh shares on conversion of warrants.Business Standard 24 Jan 2019
- Vista Pharmaceuticals awaits USFDA approval for launch of generic Dofetilide.
Business Standard 04 Jan 2019
- Vista Pharmaceuticals Signs NDA to Acquire Complex ANDA.
Medicalbuyer 31 May 2018
- Vista Pharma Submits ANDA for Cardiac Drug.
Medicalbuyer 11 May 2018
- USFDA issues warning letter to Hyderabadbased Vista Pharma Mint.
USFDA has issued a warning letter to Vista Pharmaceuticals for significant violations of current good manufacturing practice regulations for finished pharmaceuticals.
mint 12 Jul 2017
Frequently asked questions
What is the Incorporation or founding date of Vista Pharmaceuticals Ltd.?
